Earnings Projections
Search documents
Insights Into Microsoft (MSFT) Q3: Wall Street Projections for Key Metrics
ZACKS· 2025-04-25 14:20
Wall Street analysts forecast that Microsoft (MSFT) will report quarterly earnings of $3.20 per share in its upcoming release, pointing to a year-over-year increase of 8.8%. It is anticipated that revenues will amount to $68.38 billion, exhibiting an increase of 10.6% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed t ...
Stay Ahead of the Game With Paypal (PYPL) Q1 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-04-24 14:21
Core Insights - Analysts forecast that Paypal (PYPL) will report quarterly earnings of $1.15 per share, reflecting a year-over-year decline of 17.9%, with revenues expected to reach $7.83 billion, an increase of 1.6% compared to the previous year [1] Earnings Projections - Over the past 30 days, the consensus EPS estimate has been adjusted downward by 0.9%, indicating a reassessment of initial projections by covering analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue and Key Metrics - Analysts estimate that 'Revenues from other value added services' will be $667.22 million, a change of +0.3% from the prior year [5] - 'Transaction revenues' are projected to reach $7.17 billion, indicating a year-over-year change of +1.9% [5] - 'Total Payment Volume (TPV)' is expected to arrive at $420.67 billion, up from $403.86 billion in the same quarter last year [6] - The 'Transaction margin' is predicted to be 46.5%, compared to 45% in the same quarter of the previous year [6] - Analysts forecast 'Active accounts' to reach 435, up from 427 a year ago [6] - The 'Number of payment transactions' is expected to be 6,676, compared to 6,505 in the previous year [7] Market Performance - Shares of Paypal have decreased by 10.7% in the past month, contrasting with a 5.1% decline in the Zacks S&P 500 composite [7] - With a Zacks Rank 3 (Hold), PYPL is anticipated to reflect overall market performance in the near future [7]
Unveiling Astrazeneca (AZN) Q1 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2025-04-24 14:20
Core Insights - Astrazeneca (AZN) is projected to report quarterly earnings of $1.10 per share, a 6.8% increase year-over-year, with revenues expected to reach $13.68 billion, reflecting a 7.9% year-over-year growth [1] Earnings Projections - There have been no revisions in the consensus EPS estimate for the quarter over the last 30 days, indicating stability in analysts' forecasts [1] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [2] Key Metrics Estimates - Analysts predict 'BioPharmaceuticals- CVRM- Crestor- World' will reach $294.03 million, a -1% change year-over-year [4] - The estimate for 'BioPharmaceuticals- CVRM- Seloken/Toprol-XL- World' is $154.45 million, indicating a -6.4% change [4] - 'Oncology- Zoladex- World' is estimated at $268.24 million, reflecting a -2.8% change [4] Additional Product Estimates - 'Oncology- Tagrisso- World' is expected to reach $1.67 billion, a +4.6% change year-over-year [5] - The consensus for 'BioPharmaceuticals- CVRM- Crestor- U.S.' stands at $8.31 million, indicating a -16.9% change [5] - 'Other Medicines- Nexium- U.S.' is projected at $19.28 million, suggesting a -12.4% change [5] Further Product Insights - 'BioPharmaceuticals- R&I- Fasenra- U.S.' is forecasted to reach $220.22 million, a +4.9% change [6] - 'BioPharmaceuticals- CVRM- Brilinta- U.S.' is estimated at $133.59 million, indicating an -18% change [6] - 'Oncology- Lynparza- U.S.' is projected at $302.67 million, reflecting a +5.1% change [6] Oncology Product Forecasts - 'Oncology- Imfinzi- U.S.' is expected to come in at $719.14 million, a +23.6% change year-over-year [7] - 'Oncology- Calquence- U.S.' is projected at $493.39 million, indicating a -0.1% change [7] - 'BioPharmaceuticals- CVRM- Farxiga- U.S.' is estimated to reach $489.15 million, reflecting a +3% change [7] Stock Performance - Astrazeneca shares have decreased by -5.8% over the past month, compared to a -5.1% change in the Zacks S&P 500 composite [8] - With a Zacks Rank 3 (Hold), AZN is expected to perform in line with the overall market in the near future [8]
Gear Up for Alexandria Real Estate Equities (ARE) Q1 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-04-23 14:21
Core Viewpoint - Alexandria Real Estate Equities (ARE) is expected to report a decline in quarterly earnings and revenues, indicating a challenging financial outlook for the company [1][2]. Financial Projections - Analysts predict quarterly earnings of $2.28 per share, reflecting a 3% decline year-over-year [1]. - Revenues are forecasted to be $758.46 million, representing a year-over-year decrease of 1.4% [1]. - The consensus EPS estimate has been revised downward by 0.1% over the past 30 days, indicating a reappraisal of projections by analysts [2]. Key Metrics Analysis - 'Revenues- Other income' is projected to reach $16.66 million, showing a year-over-year increase of 22.9% [5]. - 'Revenues- Rental' is expected to be $749.38 million, suggesting a year-over-year decrease of 0.8% [5]. - The average prediction for 'Depreciation and amortization' is $318.88 million, compared to $287.55 million reported in the same quarter last year [5]. Market Performance - Alexandria Real Estate Equities shares have decreased by 20.6% in the past month, contrasting with the Zacks S&P 500 composite's decline of 6.6% [6]. - The company holds a Zacks Rank 4 (Sell), indicating expectations of underperformance relative to the overall market in the near term [6].
Unlocking Q1 Potential of Ameris Bancorp (ABCB): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-04-23 14:21
Core Insights - Ameris Bancorp (ABCB) is expected to report quarterly earnings of $1.15 per share, a 4.6% increase year-over-year, with revenues projected at $278.8 million, reflecting a 3.9% increase [1] - Analysts have revised the consensus EPS estimate upward by 0.8% over the past 30 days, indicating a collective reassessment of projections [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Financial Metrics - Analysts estimate a 'Net interest margin (TE)' of 3.6%, up from 3.5% a year ago [5] - The 'Efficiency ratio' is projected to be 56.6%, compared to 55.6% in the same quarter last year [5] - 'Nonaccrual loans' are expected to reach $98.61 million, down from $164.69 million in the same quarter last year [6] - The consensus for 'Average Balances - Total Earning Assets' is $24.22 billion, an increase from $23.21 billion a year ago [6] - 'Total non-performing assets' are projected at $125.21 million, down from $182.68 million in the same quarter last year [7] - 'Net Interest Income (TE)' is expected to be $214.47 million, compared to $202.34 million a year ago [7] - 'Total Non-Interest Income' is forecasted at $64.32 million, slightly down from $65.88 million a year ago [8] - 'Net Interest Income' is projected to reach $212.85 million, up from $201.39 million a year ago [8] Market Performance - Over the past month, Ameris Bancorp shares have declined by 8.7%, while the Zacks S&P 500 composite has decreased by 6.6% [9] - Based on its Zacks Rank 2 (Buy), Ameris Bancorp is expected to outperform the overall market in the upcoming period [9]
Countdown to Federated Hermes (FHI) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-04-23 14:21
Core Viewpoint - Analysts project that Federated Hermes (FHI) will report quarterly earnings of $0.91 per share, reflecting a 2.3% year-over-year increase, with revenues expected to reach $421.56 million, a 6.4% increase from the same quarter last year [1] Earnings Projections - Over the past 30 days, the consensus EPS estimate has been adjusted downward by 7.5%, indicating a reassessment by covering analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts estimate 'Revenue- Administrative service fees, net-affiliates' at $99.96 million, a year-over-year increase of 5.5% [5] - 'Revenue- Other service fees, net' is projected at $36.97 million, indicating a decrease of 0.9% from the prior-year quarter [5] - 'Revenue- Investment advisory fees, net' is expected to be $283.63 million, reflecting a 7.3% increase from the year-ago quarter [6] Asset Class Projections - 'Managed Assets - Long-term assets - Alternative/private markets' is estimated to be $20.00 billion, down from $20.47 billion reported in the same quarter last year [6] - 'Managed Assets - Long-term assets - Multi-asset' is projected at $2.91 billion, slightly down from $2.93 billion year-over-year [7] - 'Managed Assets - Money market' is expected to reach $634.16 billion, up from $578.81 billion a year ago [7] Fund Assets Estimates - 'Fund Assets - Funds - Long-term assets - Alternative/private markets' is projected at $12.20 billion, down from $12.46 billion year-over-year [8] - 'Fund Assets - Funds - long-term assets - Multi-asset' is expected to be $2.78 billion, slightly down from $2.79 billion [8] Separate Accounts Projections - 'Separate Accounts - Long-term assets - Alternative/private markets' is estimated at $7.80 billion, down from $8.01 billion year-over-year [9] - 'Separate Accounts - Long-term assets - Multi-asset' is projected at $127.93 million, down from $139 million in the same quarter last year [10] - 'Separate Accounts - Money market' is expected to reach $171.34 billion, up from $161.71 billion year-over-year [10] Stock Performance - Shares of Federated Hermes have decreased by 9.7% over the past month, compared to a 6.6% decline in the Zacks S&P 500 composite [11]
Countdown to Aon (AON) Q1 Earnings: Wall Street Forecasts for Key Metrics
ZACKS· 2025-04-22 14:21
Core Insights - Analysts project Aon (AON) will report quarterly earnings of $6.04 per share, reflecting a 6.7% year-over-year increase, with revenues expected to reach $4.86 billion, a 19.3% increase from the same quarter last year [1] Revenue Projections - Revenue from 'Reinsurance Solutions' is forecasted to be $1.23 billion, indicating a 5.7% increase from the previous year [4] - 'Health Solutions' revenue is expected to reach $1.04 billion, showing a significant increase of 42.4% year-over-year [4] - 'Commercial Risk Solutions' revenue is projected at $2.10 billion, reflecting a 16.3% increase from the prior year [4] - 'Wealth Solutions' revenue is anticipated to be $499.98 million, marking a 35.1% increase from the year-ago quarter [5] Organic Revenue Growth Estimates - 'Commercial Risk Solutions - Organic Revenue Growth' is expected to be 5.5%, up from 3% reported in the same quarter last year [5] - 'Reinsurance Solutions - Organic Revenue Growth' is projected at 5.7%, down from 7% in the previous year [6] - 'Wealth Solutions - Organic Revenue Growth' is estimated to be 5.2%, compared to 4% reported last year [6] - 'Consolidated - Organic Revenue Growth' is forecasted at 5.7%, slightly up from 5% in the same quarter last year [7] - 'Health Solutions - Organic Revenue Growth' is expected to be 5.9%, down from 6% reported in the previous year [7] Stock Performance - Aon's shares have shown a return of -9.5% over the past month, compared to a -8.9% change in the Zacks S&P 500 composite [7] - AON holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the overall market in the near future [7]
Countdown to Old National Bancorp (ONB) Q1 Earnings: Wall Street Forecasts for Key Metrics
ZACKS· 2025-04-21 14:21
Core Insights - Old National Bancorp (ONB) is expected to report quarterly earnings of $0.42 per share, reflecting a decline of 6.7% year over year, while revenues are forecasted to increase by 8.7% to $478.3 million [1] - Analysts have revised the consensus EPS estimate upward by 4.4% over the past 30 days, indicating a collective reassessment of projections [2] - The relationship between earnings estimate revisions and short-term stock price performance is well-documented, highlighting the importance of these revisions for investor behavior [3] Financial Metrics - The consensus 'Efficiency Ratio' is projected to be 54.9%, down from 58.3% in the same quarter last year [5] - 'Net interest margin (FTE)' is expected to remain stable at 3.3%, consistent with the year-ago figure [5] - Analysts predict 'Average Balance - Total earning assets' to be $48.47 billion, an increase from $44.18 billion reported in the same quarter last year [5] Income Projections - 'Total noninterest income' is expected to reach $88.16 million, up from $77.52 million in the same quarter last year [6] - 'Net Interest Income (FTE)' is forecasted at $390.14 million, compared to $362.71 million in the same quarter last year [6] - 'Service charges on deposit accounts' are projected to be $20.09 million, an increase from $17.90 million in the same quarter last year [7] - 'Wealth and investment services fees' are expected to reach $30.16 million, up from $28.30 million in the same quarter last year [7] - 'Mortgage banking revenue' is anticipated to be $6.66 million, compared to $4.48 million in the same quarter last year [8] Stock Performance - Over the past month, shares of Old National Bancorp have declined by 7.6%, while the Zacks S&P 500 composite has decreased by 5.6% [9] - ONB currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [9]
Seeking Clues to Intel (INTC) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-04-18 14:20
Core Viewpoint - Analysts forecast Intel (INTC) will report quarterly earnings of $0.01 per share, reflecting a year-over-year decline of 94.4%, with revenues expected to be $12.32 billion, down 3.2% from the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 2.1% in the last 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts estimate 'Net Revenues- Total Intel Products Group- Client Computing Group' will reach $6.86 billion, a year-over-year decline of 9% [5]. - 'Net Revenues- Total Intel Products Group- Network and Edge' is projected at $1.41 billion, reflecting a 3.1% increase from the prior year [5]. - 'Net Revenues- Total Intel Products Group- Data Center and AI' is expected to be $2.97 billion, indicating a 2% decline year-over-year [6]. - 'Net Revenues- Intel Foundry Services' is estimated at $4.25 billion, down 2.7% from the previous year [6]. - 'Net Revenues- All other- Mobileye' is projected to reach $449.28 million, suggesting an 88% increase year-over-year [6]. - The estimated 'Net Revenues- All other- Other' is $140.08 million, indicating a decline of 27.8% from the year-ago quarter [7]. Stock Performance - Intel shares have decreased by 21% in the past month, compared to a 6.9% decline in the Zacks S&P 500 composite [7].
Gear Up for Texas Instruments (TXN) Q1 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-04-17 14:20
Core Insights - Texas Instruments (TXN) is expected to report quarterly earnings of $1.06 per share, reflecting a year-over-year decline of 11.7% [1] - Anticipated revenues are projected to be $3.91 billion, indicating a 6.7% increase compared to the same quarter last year [1] Earnings Estimates - There has been no revision in the consensus EPS estimate over the last 30 days, suggesting stability in analysts' forecasts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong link between earnings estimate trends and short-term stock price movements [3] Revenue Projections - Analysts estimate 'Revenue- Other' at $213.26 million, representing a year-over-year increase of 23.3% [5] - The consensus for 'Revenue- Embedded Processing' is $608.48 million, indicating a decline of 6.7% from the prior year [5] - 'Revenue- Analog' is expected to reach $3.08 billion, reflecting an 8.6% increase from the year-ago quarter [5] Operating Profit Estimates - 'Operating Profit- Analog' is projected to be $1.10 billion, up from $1.01 billion in the same quarter last year [6] - 'Operating Profit- Other' is expected to be -$56.92 million, a significant decrease from the $173 million reported in the same quarter last year [6] - 'Operating Profit- Embedded Processing' is estimated at $90.08 million, down from $105 million in the same quarter last year [7] Stock Performance - Texas Instruments shares have decreased by 19.4% over the past month, compared to a 6.3% decline in the Zacks S&P 500 composite [8] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the overall market in the near future [8]